SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " rus " 7,683 found 🔀 AI-powered Shuffle
Heastie brushes off growing DSA influence, defeat of incumbents in Albany
Heastie sought to put the results into context while speaking with reporters at an unrelated event in Schenectady on Thursday.
The Big Summer Preview
New jetbikes, grav vehicles and Dreadnoughts revealed for Warhammer 40,000 AND Warhammer: The Horus Heresy.
Health officials: State's first West Nile virus-positive mosquito of the year found in Berkshires
“With warmer weather and summer officially beginning this week, it is the time of year when we typically begin detecting West Nile virus in mosquito populations,” a public health official said.
Distrust In Science Isn't New: We Mistook Silence For Trust
Distrust in medicine and science isn't a new crisis. Drawing on decades in communities, a physician explains the real source and how we earn trust.
Yearslong Resident Evil mystery solved: Kyle MacLachlan revealed to be Jill Valentine's 'boyfriend'
Twin Peaks star has ties to STARS
Men’s Health Month reminds community members to catch up on overdue wellness visits
June is Men’s Health Month and experts are urging men not to ignore crucial preventative care.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
If I were traveling, Anker is the only company I would trust with my life to keep my tech fully charged at all times — and 11 of its best items are on sale right now
Get these Anker products to keep your gear always charged!
Dave Roberts Gives Blunt Assessment on Dalton Rushing Controversy
Dodgers catcher Dalton Rushing had a rough game on Wednesday, June 24th, behind the dish, getting into a disagreement with Shohei Ohtani.
Xbox prices spike another $100 or more
Xbox blames the memory shortage for the price hike.
Government Scientists Fired by Trump Launch New Website for Sharing Climate Data
"Trusted climate information should not disappear when politics change."
Another look at carrots and eyesight; how to get more fiber; why mosquitoes bite some people and not others; plus other stories with Vanderbilt Health sources
AARP reporter Stacey Colino interviewed Milam Brantley, MD, Associate Professor of Ophthalmology and Visual Sciences, in 2020 for a story about whether eating carrots can improve vision. Sacramento Bee reporter Samantha Agate has now used Brantley’s comments in an AI-curated story created by content specialists on the same topic that has been picked up by MSN and others. Prevention magazine interviewed Heidi Silver, RD, PhD, Founding Director of the Vanderbilt Diet, Body Composition, and Human Metabolism Core, for a story about the importance of fiber and how people can get more of it in their diet. William Schaffner, MD, Professor of Preventive Medicine, was quoted by several news outlets about public health issues, including: Women’s Health (tick bites and alpha-gal syndrome); The Washington Post (tetanus); and Healthline (why mosquitoes prefer to bite some people and leave others alone). A visit to Monroe Carell Jr. Children’s Hospital at Vanderbilt by some Banana Ball baseball players was covered by The Tennessean and WZTV Fox 17 News, and The Tennessean’s story was also picked up by Yahoo! Sports. Clarksville Now published a story written by the Montgomery County Economic Development Team, whointerviewed Bradley Stancombe, MD, professor of Clinical Pediatrics, Vanderbilt Neonatology, about the new energy of Vanderbilt Clarksville Hospital and how the facility is recruiting physicians. Healio Allergy/Asthma group editorial director Richard Gawel interviewed Mark Rolfsen, MD, Clinical Fellow in the Division of Allergy, Pulmonary and Critical Care Medicine, for a story about his presentation at the American Thoracic Society meeting on metal health outcomes following ICU discharge. Nashville Scene reporter Hannah Herner interviewed James Crowe, MD, Director of the Vanderbilt Center for Antibody Therapeutics, for a story about his efforts to prepare for the next pandemic by isolating antibodies that can neutralize dangerous viruses. Medscape reporter Kathleen Doheny interviewed Neesha Choma, Associate Chief of Staff of Vanderbilt University Hospital, for a story about how hospitals can reduce readmissions.
Bluehost Launches Inaugural Market Study on State of Small Business AI Confidence in the U.S.
/PRNewswire/ -- Bluehost, the SMB business platform that millions of small businesses, developers, and agencies globally trust to run, grow and scale in the AI...
Rush CEO to step down, take health equity mission to national stage
Dr. Omar Lateef said he is handing off a health system at the top of its game and expects healthcare leaders from around the nation will be clamoring to fill the role.
Steve Zabel, throwback two-way player, dies at 78
Steve Zabel, a tight end and pass rusher who was Oklahoma's last two-way player and then played both positions in the NFL, has died at the age of 78.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
KFF Poll Shows Three in Ten Adults Turn to Social Media or AI for Health Information, with Lower-Income Adults More Likely to Cite Cost and Access Barriers as a Reason
The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences or a desire for quick information.
Democracy’s Defenses, Democracy’s Undoing
A broad range of views on democracy to help break the stalemate caused by partisan conflict.
Bacteria-killing viruses redirect vaccine immunity to destroy cancer
Phages, viruses that infect bacteria, could be genetically manipulated to destroy cancerous cells using the immunity we have acquired from vaccines
Meta's reckoning has arrived
After years of layoffs, restructuring, and hard-charging management tactics, Meta's leaders are acknowledging a collapse in employee trust and morale.
Report: Trust In Public Health Is Strongest at the Local Level
Federal advice is now viewed with skepticism, opening a door for state and local leadership.
Shohei Ohtani calls his own pitches vs. Twins after apparent dispute with catcher Dalton Rushing
Dodgers Overcome Dalton Rushing’s Mental Struggles to Sweep Twins
The Los Angeles Dodgers swept the Minnesota Twins on Wednesday despite some struggles by catcher Dalton Rushing.
Families, business owners push leadership to break silence following Haywood Mall shooting
Eleven days after shots rang out at Haywood Mall in Greenville, families and business owners are growing frustrated by the lack of answers from Simon Corporate and Upstate-based mall management.
US public health agency concludes hantavirus response as outbreak eases
The US Department of Health and Human Services has announced the end of the monitoring period for the virus.
Ryman Hospitality Properties, Inc. Addresses Recent Media Reports Regarding Opry Entertainment Group
NASHVILLE, Tenn., June 24, 2026 (GLOBE NEWSWIRE) -- Ryman Hospitality Properties, Inc. (NYSE: RHP) (the “Company”), a leading lodging and hospitality real estate investment trust that specializes in group-oriented, upscale convention center resorts and entertainment experiences, today addressed recent media reports regarding the Company’s Opry Entertainment Group (“OEG”) business. Colin Reed, Executive Chairman of Ryman Hospitality Properties said, “We are incredibly proud of our OEG business an
Trump spoke with Live Nation CEO shortly before surprise Justice Department settlement, court filing reveals
Live Nation’s chief executive spoke with President Donald Trump less than a month before the ticketing and events giant reached a surprise antitrust settlement with the Justice Department that consumer advocate groups have largely panned.
Giant viruses discovered on Greenland ice sheet may slow glacial melting - Futura-Sciences
Giant viruses defy microbiological norms Lead author Laura Perini and her team at the Department of Environmental Science at Aarhus University identified the microorganisms during a field survey of Arctic ice. Measuring up to 2.5 micrometers in length, these viral specimens are roughly 125 times larger than conventional viral strains....
Leslie Jones says being typecast as 'angry' on 'SNL' was 'frustrating'
Former "Saturday Night Live" star Leslie Jones is looking back on the "frustrating" feeling of being typecast as a certain kind of "angry" character on the show.
HHS Successfully Concludes Hantavirus Response Effort; Monitoring Ends with No Positive U.S. Case
HHS announced the successful conclusion of the federal public health response to the Hantavirus exposure event associated with the M/V Hondius cruise ship.
As Ebola cases surge above 1,000, experts say outbreak could be worst ever
Insufficient contact-tracing and the refusal of many residents to avoid contact with the bodies of loved ones killed by the Ebola virus are accelerating the epidemic.
Several overnight business break-ins reported in Cabarrus County
Break-ins were reported in Concord, Harrisburg and Kannapolis.
A preventable tragedy: What my sister’s death taught me about public health
Rabies is 100% preventable when institutions work together. We must engage trusted community leaders and break down siloes between animal and human health.
Scientists discover hidden “footprints of death” that may help viruses spread
Scientists have uncovered a surprising new twist in what happens when cells die. As dying cells break apart, they leave behind tiny “footprints of death” packed with newly discovered particles that help guide the immune system to clean up the remains. But researchers found that influenza viruses can exploit this process, hiding inside these microscopic packages and potentially using them to spread to nearby cells.
EU Proposes Tax Simplification Measures in Bid to Boost Business
The European Union unveiled a new package to overhaul the bloc’s tax rules on Wednesday, the latest effort by Brussels to cut red tape and reduce the regulatory burden on business.
In the Ebola epicenter, a gold-mining town reacts with fear, disbelief and grit
NPR reports from Mongbwalu in the Democratic Republic of Congo. The fight to contain the virus faces obstacles from lack of supplies to residents who doubt that the virus is real.
4 Takeaways From England-Ghana Scoreless Stalemate At World Cup
A gritty draw for Ghana over an England team that was frustrated all day sets up a thrilling finale in group stage play.
Hollywood is bending the knee to OpenAI
Buy Luca Guadagnino’s Sam Altman film, you cowards.
In symbolic vote, Congress directs Trump to remove forces from Iran war
The measure to remove U.S. armed forces from hostilities with Iran does not require the president's signature, nor does it carry the force of law. But it reflects bipartisan frustration with the war.
WATCH: Trump says nuclear inspectors will be able to enter Iran at 'appropriate time'
President Donald Trump insisted Tuesday that Iran agreed to United Nations watchdog inspections of its nuclear sites, but said there is "no rush."
Roku May Help Fox Avoid Aggregeddon
(Welcome to the “Most Important Story of the Week”, my bi-weekly strategy column analyzing the most important (but often not buzziest) news story of the last two weeks. I’m the Entertainment Strategy Guy, a former streaming executive who now analyzes business strategy in the entertainment industry. Please subscribe.) Scrolling through links over the last week, I stumbled across this fun headline: Wow. Formula 1 (the sport, not the docu-series) is the perfect “dog not barking”. As a reminder, each week in my Streaming Ratings Report, I call out the shows that miss every viewership chart. I dub them “dogs not barking”—like the Sherlock Holmes mystery—because without any data, we forget they even exist. This is in contrast to something like, say, a film flop—cough The Mandalorian and Grogu cough—where even underperforming at the box office is widely discussed here, there and everywhere. In the US, Formula 1 is now in “no public viewership data, so not discussed” territory. After moving to Apple TV from its former home of ESPN, basically no one talks about it. Apple did publish an initial, unsourced, unsubstantiated, (dare I say unserious) datecdote claiming more folks are watching Formula 1 on Apple than ESPN, but we haven’t gotten any updates since. This stands in contrast to when the sport streamed on ESPN, and ESPN PR provided weekly viewership figures. Formula 1 was, at best, a niche sport in America—averaging 1.3 million viewers in the Big Data Plus era—but now it’s basically anonymous. (And yeah, after moving to Apple, I very, very, very much doubt its ratings increased.) Unfortunately, that story isn’t quite big enough to warrant a section in today’s “Most Important Story of the Week” column, but I wanted to call it out, because otherwise, no one else will! Certainly, no one will write articles about the silence/ratings decline, unlike when they wrote breathless articles connecting the rise in viewership to Netflix’s Drive to Survive, including Reuters just last month. (This is a topic I’ve tried to provide a moderate/nuanced/non-hyped take since 2022.) Anyway, on to this week’s issue. I was a bit worried I didn’t have a juicy topic, then the Murdochs went out and did their Murdoch thing: buying Roku. So that’s the story of the week, and it happens to touch on quite a few themes of the streaming wars and the disruption therein. I’ll cover that, plus why more consolidation in Hollywood media looks likely, more good news on the Hollywood labor front, whether we’ll see an uptick in production in Los Angeles, some Broadway and theme park news, cellphone prices going up in the third world (and possibly everywhere), and more. Subscribe Most Important Story of the Week - Another Big Media & Entertainment Merger The story of the week is clearly Fox is buying Roku for $22 billion. I read a lot of good strategy takes on why Fox bought this streaming TV device maker—and I’ll have mine below—but what fascinates me more is how this deal connects to quite a few themes of the streaming wars, linking to everything from the pace of M&A to “aggregeddon” to Netflix’s recent M&A actions/inactions to the shift to advertising from pure play streaming and more. The only topic I can’t really connect it to is my old theory, “never bet against Rupert Murdoch” because he isn’t the one who did this deal; his son Lachlan inked it. (Do I think he provided advice, even at his 95 years of age? Sure.) That plus I have one additional piece of strategy for all entertainment players, inspired by this deal. So let’s dive into all those topics, starting with why I like this deal. Roku is a Great M&A Buy
Notorious Xbox and PS5 shovelware publisher booted off PlayStation Store
Sony is continuing its crusade against low-effort shovelware titles and is now delisting close to 1,000 Afil Games titles from the PlayStation platform.
12 Things Health Agencies Need to Know About Enterprise AI
Learn how Minnesota's health agency is effectively adopting AI tools for public health work.
Back door no more: Griffin Museum of Science and Industry seeks to reopen its south entrance after a century
The museum plans to break ground this year on a $22 million project that will reopen the 133-year-old edifice's south entry and add an indoor cafe with seating on the building's outdoor renovated terrace.
Behind this “ordinary snake,” scientists stunned by a hidden new species - Futura-Sciences
A Mysterious Snake Revealed Researchers from the Chengdu Institute of Biology, partnering with the Giant Panda National Park, have officially described a new species of tree viper: Trimeresurus lii, affectionately dubbed the Huaxi green viper. The discovery was made in early 2025 and published in the open-access journal Zoosystematics and...
Why Combat Sports Continue to Attract Global Audiences
No sports experience can beat the adrenaline rush of witnessing two opponents battle each other on equal footing, armed only with skills, preparation, and sheer willpower. Throughout the ages, boxing, MMA, wrestling, and judo have continued entertaining people all over the globe, uniting fans from many different backgrounds with a common language. Discover how fascinating […] The post Why Combat Sports Continue to Attract Global Audiences appeared first on Native News Online.
LIVE AT 9: Health officials to discuss end of hantavirus monitoring operation in Omaha
Tuesday morning, local health officials are expected to provide an update on cruise ship passengers who were monitored in Omaha.
Caitlin Clark, DeWanna Bonner altercation leads to six technical fouls, frustration from Clark: 'It's ridiculous'
Student Turns LEGO Resale Hobby Into $50,000 Business
Cedarville University senior Micah Torres turned a LEGO minifigure hobby into Rusty’s Figs, a business generating $50,000 in revenue. Through mentorship, faith and...
Atlanta Braves News: Tarik Skubal, Drake Baldwin, More
Frustrating results continue for the Braves.
This four-winged dinosaur may have terrorized Earth's earliest birds
A newly discovered feathered dinosaur called Jian changmaensis may be the missing predator responsible for mysterious piles of crushed prehistoric bird bones in China. The four-winged glider, a close cousin of Velociraptor, helps reveal how early birds and their dinosaur relatives shared the same ancient landscape.
Why Small Businesses Are Winning The AI Race With Agentic AI
Small businesses building agentic AI from scratch are outpacing larger competitors. The obstacle was never the technology, but ownership and trust.
Back door no more: Museum of Science and Industry seeks to reopen its south entrance after a century
The museum plans to break ground this year on a $22 million project that will reopen the 133-year-old edifice's south entry and add an indoor cafe with seating on the building's outdoor renovated terrace.
The Sports Report: Dodgers defeat the Twins but lose two players
The Dodgers edge the Twins, but Kyle Tucker leaves the game with back spasms and Dalton Rushing with a possible concussion.
House, Senate health chairs Creekmore and Bryan say rural health program, spending need more transparency
Senate Public Health Chairman Hob Bryan said the lack of transparency around the governor's program to spend millions in federal rural health dollars in Mississippi is "almost the Saturday Night Live parody of secrecy." Bryan and his House counterpart, Chairman Sam Creekmore, share their frustrations over lack of input from communities, and the Legislature, in how the state spends federal rural health care money.
Scientists Finally Find Out Why Gold Never Rusts Like Other Metals
Gold’s pristine shine may depend on an until now hidden atomic rearrangement at its surface.
9 of the best technology conspiracy theories
From covert government surveillance to wireless signals transmitting viruses, tech-centric conspiracy theories have been propagating wildly in recent years. Most of them are completely unfounded — but not all.
New framework renders AI trustworthy for cancer subtyping
The framework, reported in Nature Biomedical Engineering, is broadly adaptable as a wrapper for digital pathology AI systems.
ANALYSIS: Fear not Britain, the EU doesn't agree on you rejoining either
Brussels heavyweights are clashing over whether Brexit can be reversed and on what terms
Dalton Rushing Replaced After Being Hit With Foul Tip
Los Angeles Dodgers backup catcher Dalton Rushing left Monday’s game against the Minnesota Twins, making room for backup Chuckie Robinson. The Dodgers revealed Rushing is in concussion protocol after a foul tip caught the crown of his helmet in the…
Non-communicable diseases: how local coalitions can help
Place-based coalitions can help tackle NCDs. Community ownership is vital because prevention and behaviour change depend on trust and local legitimacy.
Data Is the New Blood Test: Who Owns It, Who Profits, Who Protects It?
Health data can drive better care, but patients must first be able to trust who controls it — and understand why it is being used.
Warhammer Studio goes super-heavy for an Age of Darkness tank war
Fellblade, Glaive, or Falchion – which is your favourite Warhammer: The Horus Heresy super-heavy tank?
Why the forces that felled Keir Starmer threaten so many western leaders
British Prime Minister Keir Starmer was felled by a curse haunting most western leaders — a failure to deliver change to voters who’ve lost trust in the capacity of modern politics to make their lives better and more affordable.
Cavs final report card: Max Strus
Injuries did not derail Strus’s impact in the postseason.
Valve's Steam Machine ships June 29 for $1,049, but you probably won't be able to buy one yet
Valve says it's using a randomized purchase queue to make the experience "less frustrating and more fair."
Andes Virus Outbreak on a Cruise Ship: Current Situation
Current situation on the hantavirus outbreak that was reported May 2, 2026.
Monday Morning Minnesota: The “In Buck We Trust” Edition
Do we have an MVP candidate on our hands?
Why Democrats are running against the ‘Epstein class’
Candidates are casting their messaging around Epstein’s associates and the unaccountable elite, betting that voter distrust of powerful institutions can help them shape the midterm debate.
The Torture Chamber of British Politics Crushes Its Latest Prime Minister
Keir Starmer becomes the sixth Prime Minister over the past decade to resign, surrendering to the U.K.’s manifold problems.
UVA Names Darden Vice Dean as Business School’s New Leader
Yael Grushka-Cockayne, an accomplished international scholar and leader, has served on Darden’s faculty since 2009.
UVA names Darden vice dean as business school’s new leader
Yael Grushka-Cockayne, an accomplished international scholar and leader, has served on Darden’s faculty since 2009.
Monday, June 22, 2026: The Club says this legacy tech stock's foundry business presents a major opportunity
Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market's biggest headlines, analyst calls and holdings in the Charitable Trust—and see up close how they decide when, and if, to take action on stocks.
Ultima's creator Richard Garriott is planning to win back the rights to his legendary RPG from EA with an 50-year-old copyright quirk
Speaking to Inside Games, the creator of Ultima has expressed frustration with the handling of the series since he sold it.
Anyone can fake a scientific image with AI, tricking even academic journals – and undermining trust in science
Several scientific fields rely on visual evidence to illustrate their claims. Inaccurate AI-generated images put the credibility of science at risk.
Nico Schlotterbeck’s World Cup is over through injury
Germany defender Nico Schlotterbeck has been ruled out of the rest of the World Cup through injury, Sky Germany confirms. The Borussia Dortmund defender sustained an ankle injury during the first hal...
'Relief, recovery, and rebuilding': Dogwood Health Trust releases Hurricane Helene response playbook
The Dogwood Health Trust released a Hurricane Helene playbook with lessons learned for funders before and after disaster.
How remote work, flexible schedules created a never-ending rush hour
Americans are using newfound flexibility to commute at weird hours, which means we're stuck in a never-ending rush hour.
AORUS RTX 5090 owner checks GPU after higher fan speeds, finds thermal gel mess
A GeForce RTX 5090 AORUS owner has opened the card after more than a year of use (and end of warranty) and found a large amount of factory-applied thermal…
Ukraine squeezes Russian stronghold with new drones, forcing fuel cuts
Kyiv's new mid-range drones are pounding the roads, fuel depots, and bridges connecting Crimea to Russia and the southern front lines.
Ebola Cases Top 1,000 in Congo as Virus Infects Frontline Health Workers
Ebola cases have surpassed 1,000 in the Democratic Republic of the Congo, where health workers are becoming infected before anyone realizes they’re treating the deadly virus, exposing a dangerous weakness in efforts to contain one of the world’s fastest-growing outbreaks.
Jana Kramer almost quit “DWTS” because of 'Russian' teaching techniques: 'Do not speak to me that way'
The "One Tree Hill" star bonded with Hannah Brown, who won "DWTS" season 28, over the intense training experience that viewers don't get to see.
T. rex took 40 years to reach full size, scientists find
Tyrannosaurus rex may have been a much slower grower than scientists realized. A new study of 17 tyrannosaur fossils found that the giant predator likely took about 40 years to reach its full size of roughly eight tons, extending previous estimates by 15 years.
What Would Faster Sequencing Mean for Your Research?
In this Teach Me In 10, Dr. Nick Scales, Technical Sequencing Specialist at Plasmidsaurus, discusses how Plasmidsaurus help researchers gain deeper biological insights while reducing common workflow bottlenecks.
Insider Shares Timeframe For Potential T.J. Watt Trade
Pittsburgh could look to trade star pass rusher T.J. Watt.
At Atlanta church, Ossoff casts Senate race as test of faith, character and democracy: "Georgia's spirit of tolerance will overwhelm and defeat bigotry"
Speaking at Beulah Missionary Baptist Church, Sen. Jon Ossoff urged voters to look beyond campaign rhetoric and examine the records of candidates seeking public trust.
'Out of hand': Paraguay coach Alfaro vents at World Cup's business elite
Paraguay's outspoken coach Gustavo Alfaro took aim at football's business elites on Sunday, accusing them of commercial intrusion on the World Cup and sidelining fans with exorbitant ticket costs in a sport that has its roots in poverty.
'Toy Story 5' crushes the box office on opening weekend
"Toy Story 5" grossed an estimated $160 million domestically and $152 million internationally after debuting in theaters on Friday.
Japan takes massive leap in the World Cup Power Rankings
Japan crushed Tunisia in the 1,000th World Cup game ever played and are looking like a legitimate contender this summer.
Dirty politics, dirty soda and dirty Mormon wives
A young neighbor's entrepreneurial enterprise leads to an astounding television show that helps explain our national morass.
8 years ago, Square Enix ushered in a new era with this stroke of genius
Other game companies should copy this
Ukraine spy and attack drones now bringing supplies to soldiers
Ukraine's front lines with Russia has become so dangerous that it wants to use as many unmanned systems as it can, including drones to carry gear.
Some More Coors Field Frustration for Pirates
A bizarre interference call at third base stifled a bases-loaded rally in Denver, handed the Pittsburgh Pirates another one-run loss, and pushed the struggling club below the .500 mark.
England vs New Zealand: Matt Henry ends hosts' miserable fortnight
England's miserable fortnight ends with a crushing defeat in the second Test against New Zealand at The Oval - setting up a high-stakes decider at Trent Bridge.
Trusting Brad Stevens: (an open thread on Celtics trade rumors)
I don’t know what Brad Stevens is going to do, but he’s pretty good at his job
Opinion
Politicians now think it is fine not to release their tax returns. But that only feeds distrust.
Sunday Preview – Battleforces, MkIV Space Marines, and a Hero of the Imperium
See what’s coming up next week for Warhammer 40,000, Warhammer: The Horus Heresy, and Black Library.
Dinosaurs invaded downtown St. Paul for blockbuster 1986 Science Museum exhibit
The brontosaurus and a 10-foot-tall Tyrannosaurus rex had been floated down the Mississippi River from Minneapolis that morning on coal barges to drum up publicity for the exhibit. It worked.
Gigabyte confirms Ryzen 9 PRO 9965X3D support on consumer X870 motherboard
Gigabyte has added AMD’s new Ryzen PRO 9000 desktop processors to the CPU support list for its X870 AORUS TACHYON ICE motherboard.
Vikings Free Agent Prediction Turns Heads
ESPN insider Aaron Schatz suggests Minnesota target veteran Haason Reddick to bolster edge depth, providing Brian Flores with a versatile pass rusher to complement star Dallas Turner.